Article
Covid-19's digital imperative for biopharma and medtech - MedCity News
Rating:
0.0
Views:
68
Likes:
1
Library:
1
The disruption to biopharma and medtech businesses caused by Covid-19, such as product launch and clinical trial delays, has underscored the need for a more digital focused strategy.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value